Hypoplasminogenemia
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of Prometic Plasminogen IV Infusion in Subjects With Hypoplasminogenemia (NCT02690714) | Prometic Biotherapeutics, Inc. | 2016-05-04 |
| A Phase 1 Study of ProMetic Plasminogen (Human) Intravenous in Adults and Children With Plasminogen Deficiency (NCT02312180) | Prometic Biotherapeutics, Inc. | 2014-12-01 |
| A Single-patient Study of Repeat-dose Administration of Prometic Plasminogen (Human) Intravenous (NCT03265171) | Prometic Biotherapeutics, Inc. | |
| A Treatment Protocol for Expanded Access Administration of Prometic Plasminogen Due to Closure of Clinical Trial (NCT03642691) | Prometic Biotherapeutics, Inc. |
Track Hypoplasminogenemia automatically
Every clearance here is in the API, with alerts when new ones post.